- Supplements Facts
- Scientific References
- Client Reviews
Stay Active and Moving with this Advanced Joint and Muscle Formula...
TrueJoint FLX™ is formulated to target over 40 different causes of everyday pain and stiffness. So if you’re looking to mover better, recover more quickly from physical activity or just keep joints and muscles healthy, TrueJoint FLX™ is for you.
TrueJoint FLX™ is now in its sixth generation, regularly improved over the last 12 years to offer the best nutritional support for joints and muscles. Here are the five clinically studied ingredients in this advanced formula:
BCM-95®: Maximizing the Potency of Curcumin
This patented ingredient combines curcumin and turmeric oils from the turmeric spice to boost absorption and potency. It has been shown in 12 clinical studies to support a healthy inflammation response, aiding joint and muscle health and supporting normal function of certain other parts of the body.
ApresFLEX®: The Clinically Studied Boswellia Serrata: Boswellia has been used for thousands of years in traditional medicine for joint health. Modern science has validated the benefits of a premium boswellia extract called ApresFLEX®. In several clinical trials, ApresFLEX® has been shown to help joint discomfort and stiffness starting in just five days.
ParActin®: Helps You Move Better With Less Stiffness: A patented extract of the andrographis paniculata plant, ParActin® has been the subject of two clinical studies conducted by researchers from the Universidad Austral de Chile. Both of these studies have shown ParActin® helps joint discomfort, allowing users to move better with less stiffness.
TendoGuard™: Strengthens Cartilage and Connective Tissue: A potent combination of four types of collagen (Types I, II, V, X), hyaluronic acid (HA), chondroitin sulfate and other beneficial mucopolysaccharides. Together these nutrients help joint connective tissues recover - helping to reduce discomfort, strengthen muscles and improve mobility.
BCM-95®: Made From the Finest Turmeric Grown with Organic and Sustainable Farming Practices
The best turmeric is grown in a frost free climate that gets plenty of rain - but in soil that drains rapidly.
You’ll find these conditions in northeast India - which is why this region is known for producing the finest turmeric plants. The turmeric for BCM-95® comes from this region, in Northeast India.
The local farmers are very careful about the organic farming techniques they use. You won’t find pesticides or harsh chemical fertilizers on the farms used to make BCM-95®.
Instead they strictly use natural fertilizers like animal manure and repurposed turmeric roots, rhizomes and leaves.
Most of the work, including harvesting, is done by hand. From start to finish, very little machinery is used.
Since turmeric is such an important crop to the region, the locals are careful to use eco-friendly and sustainable practices.
The makers of BCM-95® make sure the farmers are paid reasonable, competitive prices for their crops.
The challenge with curcumin for everyday use has been that once extracted from turmeric, it’s poorly absorbed in the bloodstream during digestion.
So you had to take very large doses to get desired benefits - this is both expensive and hard to do each day. This problem has been overcome with the introduction BCM-95®.
BCM-95® improves absorption using a patented process that combines curcumin with essential oils also found in turmeric.
The bottom line is when comparing absorption and sustainability in the bloodstream, just 400mg of BCM-95® is equivalent to 2,500mg of regular curcumin.
In addition to blood work, the enhanced absorption of BCM-95® was confirmed by analyzing stool samples. This showed that only 5%-10% of BCM-95® is excreted (the rest is absorbed) compared to 50% -60% of regular curcumin.
There are two types of curcumin: spice grade turmeric and extractable root turmeric. BCM-95® is made from the extractable root turmeric because while it requires a more delicate and expensive process to extract the curcumin and turmeric oil, the root contains up to 300% more curcumin than regular spice grade turmeric.
As a result, harsh and potentially unsafe solvents don’t need to be used to extract the curcumin from the turmeric - just ethanol and ethyl acetate.
Once extracted, the curcumin and turmeric oil are immediately tested to ensure there’s no lingering solvents (just pure, powerful curcumin and essential turmeric oil).
Other companies use the spice grade turmeric, because it’s cheaper, and then use harsh solvents like acetone - the stuff in nail polish remover and rubber cement - to try and squeeze out the curcumin. That’s not the case with of BCM-95®.
All of these efforts ensure that you get potent and safe curcumin powder!
ApresFlex®: Comforting Joints with Legendary Boswellia Serrata
For thousands of years, a gum resin from the boswellia serrata tree has been used in Ayurvedic medicine for joint discomfort.
The boswellia tree is also known as frankincense - which was one of the gifts of the Magi or the Three Wise Men.
Modern science has harnessed the power of boswellia for use in a supplement with an ingredient from India called ApresFLEX® - which helps support joint health by promoting normal levels of the 5-LOX enzyme.
The chief compound in boswellia that helps keep 5-LOX in check is called “AKBA.” ApresFLEX® contains 20% AKBA.
In addition, using a patented process, the AKBA is combined with oils from boswellia to significantly increase the absorption of AKBA into the blood-stream.
In addition to 5-LOX, additional research has determined that ApresFLEX® also helps normalize MMP-3 enzyme activity.
This is important because MMP-3 enzymes are notorious for degrading collagen - which is an important component of joint cartilage.
Some of the benefits of ApresFLEX® were shown in a study published in the International Journal of Medical Sciences.
After just 5 days, those taking ApresFLEX® started to experience less joint discomfort based on the two of the five scales used by the researchers.
By day 15, those taking ApresFLEX® experienced significant improvement on all five joint health measurements, and continued to improve through the end of the 30 day study.
It should be noted that other ApresFLEX® research has shown that joint health improvement continues through 60 days.
As important, no adverse effects of taking ApresFLEX® have been recorded.
Paractin®: Harnessing the power of the Andrographis Plant
The Andrographis paniculata plant has a long and rich history of use in Asia where it is called the “King of Bitters.”
In the venerable medicinal systems of Ayurveda and traditional Chinese medicine, practitioners provide or recommend this herb for many health concerns. Interestingly, its traditional uses are what modern medicine now knows as the source of an unhealthy inflammatory response.
ParActin® is a patented extract from the Andrographis paniculata plant, standardized to andrographolide, 14 deoxyandrographolide and neoandrographolide.
These naturally occurring phytochemicals in the Andrographis paniculata plant have been shown by researchers to have beneficial actions in supporting healthy joints, bones and muscles - which can help you maintain an active lifestyle.
ParActin® is the result of 20 arduous years of research and development. It boasts more than 30 research studies, including in vitro, in vivo animal models and human clinical trials.
ParActin® has been researched and developed to support healthy NF-kB levels and activity, which, in turn, helps support a healthy and appropriate inflammatory response.
You should also know that ParActin® is a “clean” ingredient. It is non-GMO and grown without pesticides (wild-crafted). The Andrographis paniculata used to make Paractin® is cultivated in India, China and Southeastern Asia.
What’s more, ParActin® is sustainably harvested and is processed in a GMP-certified and ISO 9001-2008-certified Quality Management Systems facility.
TendoGuard™: Helps Strengthen Cartilage and Connective Tissue
TendoGuard™ is potent combination of four types of collagen (Types I, II, V, X), hyaluronic acid (HA), chondroitin sulfate and other beneficial mucopolysaccharides.
These nutrients come from two chicken derived materials - eggshell membrane and cartilage from the sternum - both sourced and made in the USA.
One of the advantages of TendoGuard™ is it’s made using a proprietary chemical free water extraction process that preserves the important nutritional compounds. No harsh solvents or chemicals are used.
Together these nutrients help joint connective tissues recover - helping to reduce joint discomfort, strengthen muscle and improve mobility. A summary of the most important nutrients in TendoGuard™ is as follows:
Collagen (Types I, II, V, X)
The word collagen is derived from the Greek work “kola”, which means glue. This is an appropriate name because collagen is such an important component of the connective tissue in our bodies.
Collagen is simply a protein. The difference among collagen “Types” is the amino acid composition.
As we age, the amount of collagen produced by the body slows. Besides your joints, tendons and muscles, this also affects other parts of your body that depend on collagen to stay healthy - such as skin, nails, eyes, hair and bone.
To bolster the connective tissue in your body, it helps to replenish the collagen that’s lost through the normal aging process. Otherwise you’ll lose mobility, flexibility and range of motion.
TendoGuard™ provides ample amounts of Type I, Type II, Type V and Type X collagen - which are the most widely studied types of collagen.
Hyaluronic Acid (HA)
Hyaluronic acid is an important component of the fluid that lubricates your joints - which is called synovial fluid.
Synovial fluid acts as a cushion and shock absorber in your joints, so you can support weight without scraping bone on bone. Hyaluronic acid or “HA” is important because it provides needed viscosity to the synovial fluid.
Without enough HA, synovial fluid that is “too thin” can actually cause joint discomfort instead of protecting you from it. And over time this can lead to structural damage.
As you get older, HA starts to disappear - by as much as 75% - and you may hear more creaking or grinding. This joint irritation leads directly to more stiffness and discomfort.
When TrueJont FLX™ is taken as directed, it provides at least 50mg of hyaluronic acid per day from TendoGuard™, which has been shown to be more than adequate to help provide needed viscosity in joint synovial fluid.
Chondroitin sulfate and other mucopolysaccharides
In addition to collagen and hyaluronic acid, TendoGuard™ is rich in chondroitin sulfate and other beneficial mucopolysaccharides.
Mucopolysaccharides is a long word used to describe long chains of sugar molecules - healthy sugars.
One of the best known for joint health is chondroitin. Like collagen, chondroitin is a major component of joint cartilage.
Chondroitin sulfate has been shown to be useful as a supplement because it helps slow down the loss of joint cartilage. This protective benefit is not immediate - research has shown it typically takes six months for chondroitin sulfate to make a difference.
In addition, TendoGuard™ includes other mucopolysaccharides from eggshell membrane that benefit joint and muscle health.
Dietary Supplement / 120 Capsules
Serving Size: 2 Capsules
Servings per Container: 60
|Amount Per Serving (2 caps)||Amount Per Day (4 caps)|
|Amount||% Daily Value||Amount||% Daily Value|
|Vitamin D [as vitamin D3 (cholecalciferol)]||400 IU||100%||800 IU||200%|
|AprèsFlex® (Boswellia serrata gum resin extract)||50 mg||*||100 mg||*|
|BCM-95® Bio-Curcumin® (Curcuma longa) 25:1 extract (root/rhizome) [std. to 95% total Curcuminoids Complex with Essential Oils]||350 mg||*||700 mg||*|
|ParActin® (Andrographis paniculata) (blend ofAndrographolides, 14-Deoxyandrographolides, and Neo- Andrographolides)||100 mg||*||200 mg||*|
|TendoGuard™ (Blend of Avian Sternum and Eggshell Membrane, 5% (min.) hyaluronic acid, 20% (min.) Collagen Type I, II, V, X, 10% (min.) chondroitin sulfate, 20% (min.) mucopolysaccharides)||500 mg||*||1,000 mg||*|
* Daily value not established.
Other Ingredients: Rice flour, gelatin, vegetable stearic acid, vegetable magnesium stearate, silica and medium chain triglycerides.
TendoGuard™ is a trademark of Certified Nutraceuticals, Inc.
BCM-95® and Bio-Curcumin® are registered trademarks of Dolcas Biotech LLC.
AprèsFlex® is a registered trademark of Laila Nutriceuticals exclusively licensed to PL Thomas - Laila Nutra LLC. U.S. Patent #8,551,496 and other patents pending.
ParActin® is a registered trademark of HP Ingredients.
Take two (2) capsules twice a day with water (a total of four (4) capsules per day) or as directed by your health care practitioner.
TrueJoint FLX™ helps support proper joint function giving you greater comfort†.
TrueJoint FLX™ features the clinically studied ingredients TendoGuard™, Apr?sFlex®, BCM-95®, and ParActin®.
Keep out of reach of children
Store in a cool dry place
Do not use if seal is broken or missing
†These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
- Gluten Free
- Assembled in the USA
Manufactured for and Distributed by: NatureCity®
Boca Raton, FL 33487 www.naturecity.com
To re-order call toll free 1-800-593-2563
Lopresti A, Maes A, Maker G, Hood S, Drummond P. “Curcumin and major depression: A randomised, double-blind, placebo-controlled trial investigating the potential of peripheral biomarkers to predict treatment response and antidepressant mechanisms of change.” European Neuropsychopharmacology (2014)
Lopresti A, Maes A, Maker G, Hood S, Drummond P. “Curcumin for the treatment of major depression: A randomised, double-blind, placebo controlled study.” Journal of Affective Disorders, October 1, 2014 Volume 167, Pages 368–375.
Jayesh Sanmukhani, Vimal Satodia, Jaladhi Trivedi, Tejas Patel, Deepak Tiwari, Bharat Panchal, Ajay Goel and Chandra Bhanu Tripathi. “Efficacy and Safety of Curcumin in Major Depressive Disorder: A Randomized Controlled Trial.” Phytotherapy Research, 2014; 28:579-585.
Binu Chandran and Ajay Goel. “A Randomized, Pilot Study to Assess the Efficacy and Safety of Curcumin in Patients with Active Rheumatoid Arthritis.” Phytotherapy Research, 2012; 26(11):1719-25.
Kizhakkedath, et al. “Clinical evaluation of a formulation containing Curcuma longa and Boswellia serrata extracts in the management of knee osteoarthritis.” Molecular Medicine Reports, 2011; 8(5):1542-8.
Hejazi J, Rastmanesh R, Taleban F-A, Molana S-H, Ehtejab G. A pilot clinical trial of radioprotective effects of curcumin supplementation in patients with prostate cancer. J Cancer Sci Ther. 2013;5-10.
Baum et al. “Six-Month Randomized Placebo-Controlled, Double-Blind, Pilot Clinical Trial of Curcumin in Patients with Alzheimer’s Disease.” Journal of Clinical Psychopharmacology, Vol 28, Number 1, Feb 2008 pg 110-114.
Antony B, Merina B, Iyer VS, Judy N, Lennertz K, Joyal S. “A Pilot Cross-Over Study to evaluate human oral bioavailability of BCM-95, A Novel Bioenhanced Preparation of Curcumin.” Ind J Pharm Sci., 2008;70(4):445-449.
Curcumin effects on blood lipid profile in a 6-month human study. Elsevier Pharmacological Research 56 (2007) pg 509-514.
Benny M, Antony B. Bioavailability of Biocurcumax (BCM-095). Spice India. 2006; September:11-15.
Appelboom T, Maes N, Albert A. “A new curcuma extract (flexofytol®) in osteoarthritis: results from a belgian real-life experience.” The Open Rheumatology Journal, 2014 Oct 17;8:77-81.
Panahi Y, Rahimnia A, Sharafi M, Alishiri G, Saburi A, Sahebkar A. “Curcuminoid Treatment for Knee Osteoarthritis: A Randomized Double-Blind Placebo-Controlled Trial.” Phytotherapy Research, 2014 Nov;28(11):1625-31.
Shiva Ganjali, Amirhossein Sahebkar, Elahe Mahdipour, Khadijeh Jamialahmadi, Sepideh Torabi, Saeed Akhlaghi, Gordon Ferns, Seyed Mohammad Reza Parizadeh, Majid Ghayour-Mobarhan. “Investigation of the effects of curcumin on serum cytokines in obese individuals: a randomized controlled trial.” Scientific World Journal, 2014 Feb 11;2014:898361.
Chuengsamarn S, Rattanamongkolgul S, Phonrat B, Tungtrongchitr R, Jirawatnotai S. “Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial.” The Journal of Nutritional Biochemistry, 2014 Feb;25(2):144-50.
Bronte E, Coppola G, Di Miceli R, Sucato V, Russo A, Novo S. “Role of curcumin in idiopathic pulmonary arterial hypertension treatment: a new therapeutic possibility.” Medical Hypotheses, 2013 Nov;81(5):923-6.
Sahebkar A. “Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis.” Phytotherapy Research, 2014 May;28(5):633-42.
Moreillon JJ, Bowden RG, Deike E, Griggs J, Wilson R, Shelmadine B, Cooke M, Beaujean A. “The use of an anti-inflammatory supplement in patients with chronic kidney disease.” Journal of Complementary and Integrative Medicine, 2013 Jul 1;10.
Thangapazham RL, Sharad S, Maheshwari RK. “Skin regenerative potentials of curcumin.” Biofactors, 2013 Jan-Feb;39(1):141-9.
Kumar S, Ahuja V, Sankar MJ, Kumar A, Moss AC. “Curcumin for maintenance of remission in ulcerative colitis.” The Cochrane Database of Systematic Reviews, 2012 Oct 17;10:CD008424.
Xu Y, et al. “Curcumin reverses impaired cognition and neuronal plasticity induced by chronic stress.” Neuropharmacology. 2009 Sep;57(4):463-71.
Di Pierro F, et al. “Comparative evaluation of the pain-relieving properties of a lecithinized formulation of curcumin (Meriva(®)), nimesulide, and acetaminophen.” Journal of Pain Research. 2013;6:201-5.
Akazawa N, et al. Curcumin ingestion and exercise training improve vascular endothelial function in postmenopausal women. Nutrition Research. 2012 Oct;32(10):795-9.
Belcaro G, Cesarone MR, Dugall M, et al. Efficacy and safety of Meriva(R), a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. Altern Med Rev. 2010 Dec;15(4):337-44.
Cox K, Pipingas A, Scholey A. “Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population.” Journal of Psychopharmacology, 2014 Oct 2. pii: 0269881114552744.
Vishal AA, Mishra A, Raychaudhuri SP. “A double blind, randomized, placebo controlled clinical study evaluates the early efficacy of Aflapin in subjects with osteoarthritis of knee.” International Journal of Medical Sciences 2011;8(7):615-22.
Sengupta K, Kolla JN, Krishnaraju AV, et al. “Cellular and molecular mechanisms of anti-inflammatory effect of Aflapin: a novel Boswellia serrata extract.” Molecular and Cellular Biochemistry. 2011 Aug;354(1-2):189-97.
Sengupta K, Krishnaraju AV, Vishal AA, Mishra A, Trimurtulu G, Sarma KV, Raychaudhuri SK, Raychaudhuri SP. “Comparative efficacy and tolerability of 5-Loxin and Aflapin against osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical study.” International Journal of Medical Sciences.2010 Nov 1;7(6):366-77.
Other Boswellia Serrata
Belcaro G, Dugall M, Luzzi R, Ledda A, Pellegrini L, Hu S, Ippolito E. “Management of osteoarthritis (OA) with the pharma-standard supplement FlexiQule (Boswellia): a 12-week registry.” Minerva Gastroenterologica e Dietologica. 2015 Oct 22.
Rai SP, Bajpai, M. “Evaluation of efficacy of flexiqule (boswellia phyto extract) in osteoarthritis of knee.” Scholars Journal of Applied Medical. Sciences. 2013;1(4):226-32.
Moreillon JJ, Bowden RG, Deike E, Griggs J, Wilson R, Shelmadine B, Cooke M, Beaujean A. “The use of an anti-inflammatory supplement in patients with chronic kidney disease.” Journal of Complementary and Integrative Medicine, 2013 Jul 1;10.
Siddiqui MZ. “Boswellia serrata, a potential antiinflammatory agent: an overview.” Indian Journal of Pharmaceutical Sciences. 2011 May;73(3):255-61.
Sengupta K, Alluri KV, Satish AR, Mishra S, Golakoti T, Sarma KV, Dey D, Raychaudhuri SP. “A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee.” Arthritis Research & Therapy, 2008;10(4):R85.
Kimmatkar N, Thawani V, Hingorani L, Khiyani R. “Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee--a randomized double blind placebo controlled trial.” Phytomedicine, 2003 Jan;10(1):3-7.
Gupta I, Parihar A, Malhotra P, et al. “Effects of gum resin of Boswellia serrata in patients with chronic colitis.” Planta Med. 2001 Jul;67(5):391-5.
Gupta I, Parihar A, Malhotra P, Singh GB, Lüdtke R, Safayhi H, Ammon HP. “Effects of Boswellia serrata gum resin in patients with ulcerative colitis.” European Journal of Medical Research, 1997 Jan;2(1):37-43.
Madisch A, Miehlke S, Eichele O, Mrwa J, Bethke B, Kuhlisch E, Bästlein E, Wilhelms G, Morgner A, Wigginghaus B, Stolte M. “Boswellia serrata extract for the treatment of collagenous colitis. A double-blind, randomized, placebo-controlled, multicenter trial.” International Journal of Colorectal Disease, 2007 Dec;22(12):1445-51.
Hidalgo M, Hancke J, Bertoglio J, Burgos R. “Andrographolide a New Potential Drug for the Long Term Treatment of Rheumatoid Arthritis Disease.” Innovative Rheumatology, January 2013 247-270.
Zárate C.F., Cárcamo L.C., Bertoglio J.C. “Monotherapy with an Andrographis paniculata composition (Paractin® capsules) for the symptomatic relief in different chronic rheumatoid conditions and Multiple Sclerosis: Long term follow up of 17 cases.” Publication: 2012
Burgos RA, Hancke JL, Bertoglio JC, Aguirre V, Arriagada S, Calvo M, Cáceres DD. “Efficacy of an Andrographis paniculata composition for the relief of rheumatoid arthritis symptoms: a prospective randomized placebo-controlled trial.” Clinical Rheumatology, 2009 Aug;28(8):931-46.
Other Andrographis Paniculata
Phunikhom K, Khampitak K, Aromdee C, Arkaravichien T, Sattayasai J. “Effect of Andrographis paniculata Extract on Triglyceride Levels of the Patients with Hypertriglyceridemia: A Randomized Controlled Trial.” Journal of the Medical Association of Thailand. 2015 Jul;98 Suppl 6:S41-7.
Sandborn W, Targan S, Byers V, Rutty D, Mu H, Zhang X, Tang T. “Andrographis paniculata Extract (HMPL-004) for Active Ulcerative Colitis.” The American Journal of Gastroenterology, Jan 2013; 108(1): 90–98.
Saxena RC, Singh R, Kumar P, Yadav SC, Negi MP, Saxena VS, Joshua AJ, Vijayabalaji V, Goudar KS, Venkateshwarlu K, Amit A. “A randomized double blind placebo controlled clinical evaluation of extract of Andrographis paniculata (KalmCold) in patients with uncomplicated upper respiratory tract infection.” Phytomedicine, 2010 Mar;17(3-4):178-85.
Coon JT, Ernst E. “Andrographis paniculata in the treatment of upper respiratory tract infections: a systematic review of safety and efficacy.” Planta Medica, 2004 Apr;70(4):293-8.
Poolsup N, Suthisisang C, Prathanturarug S, Asawamekin A, Chanchareon U. “Andrographis paniculata in the symptomatic treatment of uncomplicated upper respiratory tract infection: systematic review of randomized controlled trials.” Journal of Clinical Pharmacy and Therapeutics, 2004 Feb;29(1):37-45.
Gabrielian ES, Shukarian AK, Goukasova GI, Chandanian GL, Panossian AG, Wikman G, Wagner H. “A double blind, placebo-controlled study of Andrographis paniculata fixed combination Kan Jang in the treatment of acute upper respiratory tract infections including sinusitis.” Phytomedicine, 2002 Oct;9(7):589-97.
Morton S, Gupta S. “TendoGuard (Egg Membrane aand Avian Collagen) Study Yields Positive Initial Results” Molecular Scientific Group 2014 January
Other Collagen (Type I and Type II)
Schauss AG, Stenehjem J, Park J, Endres JR, Clewell A. “Effect of the novel low molecular weight hydrolyzed chicken sternal cartilage extract, BioCell Collagen, on improving osteoarthritis-related symptoms: a randomized, double-blind, placebo-controlled trial.” Journal of Agricultural and Food Chemistry. 2012 Apr 25;60(16):4096-101.
Wei W1, Zhang LL, Xu JH, Xiao F, Bao CD, Ni LQ, Li XF, Wu YQ, Sun LY, Zhang RH, Sun BL, Xu SQ, Liu S, Zhang W, Shen J, Liu HX, Wang RC “A multicenter, double-blind, randomized, controlled phase III clinical trial of chicken type II collagen in rheumatoid arthritis.” Arthritis Research & Therapy. 2009;11(6):R180.
Ruiz-Benito P, Camacho-Zambrano M.M, Carrillo-Arcentales J.N., Mestanza-Peralta,M.A., Vallejo-Flores C.A., Vargas-Lopez S.V., Villacis-Tamayo R.A. and Zurita-Gavilanes L.A. "A randomized controlled trial on the efficacy and safety of a food ingredient, collagen hydrolysate, for improving joint comfort". International journal of food science and nutrition 2009;60 Suppl 2:99-113.
Zhang LL, Wei W, Xiao F, Xu JH, Bao CD, Ni LQ, Li XF. “A randomized, double-blind, multicenter, controlled clinical trial of chicken type II collagen in patients with rheumatoid arthritis.” Arthritis Rheumatology. 2008 Jul 15;59(7):905-10.
Barnett ML, Kremer JM, St Clair EW, Clegg DO, Furst D, Weisman M, Fletcher MJ, Chasan-Taber S, Finger E, Morales A, Le CH, Trentham DE. “Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial.” Arthritis & Rheumatology, 1998 Feb;41(2):290-7.
Barnett ML, Combitchi D, Trentham DE. “A pilot trial of oral type II collagen in the treatment of juvenile rheumatoid arthritis.” Arthritis & Rheumatology, 1996 Apr;39(4):623-8.
Trentham DE, Dynesius-Trentham RA, Orav EJ, Combitchi D, Lorenzo C, Sewell KL, Hafler DA, Weiner HL. “Effects of oral administration of type II collagen on rheumatoid arthritis.” Science, 1993 Sep 24;261(5129):1727-30.
Jensen GS, Attridge VL, Lenninger MR, Benson KF. “Oral intake of a liquid high-molecular-weight hyaluronan associated with relief of chronic pain and reduced use of pain medication: results of a randomized, placebo-controlled double-blind pilot study.” Journal of Medicinal Food. 2015 Jan;18(1):95-101.
Tashiro T, Seino S, Sato T, Matsuoka R, Masuda Y, Fukui N. “Oral administration of polymer hyaluronic acid alleviates symptoms of knee osteoarthritis: a double-blind, placebo-controlled study over a 12-month period.” The Scientific World Journal. Vol. 2012.
Kalman DS, Heimer M, Valdeon A, Schwartz H, Sheldon E. “Effect of a natural extract of chicken combs with a high content of hyaluronic acid (Hyal-Joint) on pain relief and quality of life in subjects with knee osteoarthritis: a pilot randomized double-blind placebo-controlled trial.” Nutrition Journal. 2008 Jan 21;7:3.
Zotkin EG, Kharitonova TV, Shkireeva SIu. “Clinical use of chondroitin sulfate in patients with osteoarthritis in geriatric practice.” Advances in Gerontology. 2014;27(2):366-75.
Zegels B, Crozes P, Uebelhart D, Bruyère O, Reginster JY. “Equivalence of a single dose (1200 mg) compared to a three-time a day dose (400 mg) of chondroitin 4&6 sulfate in patients with knee osteoarthritis. Results of a randomized double blind placebo controlled study.” Osteoarthritis Cartilage. 2013 Jan;21(1):22-7.
Railhac JJ, Zaim M, Saurel AS, Vial J, Fournie B. “Effect of 12 months treatment with chondroitin sulfate on cartilage volume in knee osteoarthritis patients: a randomized, double-blind, placebo-controlled pilot study using MRI.” Clinical Rheumatology. 2012 Sep;31(9):1347-57.
Gabay C, Medinger-Sadowski C, Gascon D, Kolo F, Finckh A. “Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial at a single center.” Arthritis & Rheumatology. 2011 Nov;63(11):3383-91.
Wildi LM, Raynauld JP, Martel-Pelletier J, Beaulieu A, Bessette L, Morin F, Abram F, Dorais M, Pelletier JP. “Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI.” Annals of the Rheumatic Diseases. 2011 Jun;70(6):982-9.
Möller I, Pérez M, Monfort J, Benito P, Cuevas J, Perna C, Doménech G, Herrero M, Montell E, Vergés J. “Effectiveness of chondroitin sulphate in patients with concomitant knee osteoarthritis and psoriasis: a randomized, double-blind, placebo-controlled study.” Osteoarthritis Cartilage. 2010 Jun;18 Suppl 1:S32-40.
Pavelka K, Coste P, Géher P, Krejci G. “Efficacy and safety of piascledine 300 versus chondroitin sulfate in a 6 months treatment plus 2 months observation in patients with osteoarthritis of the knee.” Clinical Rheumatology. 2010 Jun;29(6):659-70.
Kahan A, Uebelhart D, De Vathaire F, Delmas PD, Reginster JY. “Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial.” Arthritis & Rheumatology. 2009 Feb;60(2):524-33.
Hochberg MC1, Clegg DO. “Potential effects of chondroitin sulfate on joint swelling: a GAIT report.” Osteoarthritis Cartilage. 2008;16 Suppl 3:S22-4.
Uebelhart D. “Clinical review of chondroitin sulfate in osteoarthritis.” Osteoarthritis & Cartiliage, Volume 16, Supplement 3, October 2008, Pages S19–S21.
Mazières B, Hucher M, Zaïm M, Garnero P.”Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled study.” Annals of the Rheumatic Diseases 2007 May;66(5):639-45.
Uebelhart D, Malaise M, Marcolongo R, de Vathaire F, Piperno M, Mailleux E, Fioravanti A, Matoso L, Vignon E. “Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo.” Osteoarthritis Cartilage. 2007 Aug;15(8):979.
Vitamin D (Joint & Muscle Health)
Gendelman O, Itzhaki D, Makarov S, Bennun M, Amital H. “A randomized double-blind placebo-controlled study adding high dose vitamin D to analgesic regimens in patients with musculoskeletal pain.” Lupus. 2015 Apr;24(4-5):483-9.
McCabe P, et al. Low vitamin D and the risk of developing chronic widespread pain: results from the European Male Ageing Study. Rheumatology. 2014.
Hong Q, Xu J, Xu S, Lian L, Zhang M, Ding C. “Associations between serum 25-hydroxyvitamin D and disease activity, inflammatory cytokines and bone loss in patients with rheumatoid arthritis.” Rheumatology (Oxford). 2014 Nov;53(11):1994-2001.
Roland, K. et al. “Vitamin D and central hypersensitivity in patients with chronic pain.” Pain Medicine, 2014 Sept. Volume 15, Issue 9, pages 1609–1618.
Ohta H, Uemura Y, Nakamura T, Fukunaga M, Ohashi Y, Hosoi T, Mori S, Sugimoto T, Itoi E, Orimo H, Shiraki M. “Adequate Serum 25-hydroxyvitamin D level as an independent determinant of quality of life in osteoporosis with a high risk for fracture.”Clinical Therapeutics. 2014 Feb 1;36(2):225-35.
Laslett LL, et al “Moderate vitamin D deficiency is associated with changes in knee and hip pain in older adults:. A 5-year longitudinal study” Annals of Rheumatic Diseases, 2014 Apr;73(4):697-703
Silva AV, Lacativa PG, Russo LA, de Gregório LH, Pinheiro RA, Marinheiro LP. “Association of back pain with hypovitaminosis D in postmenopausal women with low bone mass.” BMC Musculoskeletal Disorders. 2013 Jun 12;14:184.
Glover TL1, et al. “Vitamin D, race, and experimental pain sensitivity in older adults with knee osteoarthritis.” Arthritis & Rheumatology. 2012 Dec;64(12):3926-35.
Kragstrup, T “Vitamin D supplementation for patients with chronic pain” Scand J Prim Health Care. Mar 2011; 29(1): 4–5.
Halliday TM, et al. “Vitamin D status relative to diet, lifestyle, injury, and illness in college athletes.” Medicine & Science in Sports & Exercise. 2011 Feb;43(2):335-43.
Cannell JJ, et al. “Athletic performance and vitamin D.” Med Sci Sports Exerc. 2009 May;41(5):1102-10.
Broe KE, et al. “A higher dose of vitamin d reduces the risk of falls in nursing home residents: a randomized, multiple-dose study.” Journal of the American Geriatrics Society. 2007 Feb;55(2):234-9.
Ruohola JP, et al. “Association between serum 25(OH)D concentrations and bone stress fractures in Finnish young men.” Journal of Bone and Mineral Research. 2006 Sep;21(9):1483-8.
de la Jara GDT, Pecoud A, Favrat B. “Female asylum seekers with musculoskeletal pain: the importance of diagnosis and treatment of hypovitaminosis D”. BMC Family Practice. 2006;7(4).
Bischoff-Ferrari HA, et al. “Effect of Vitamin D on falls: a meta-analysis.” The Journal of the American Medical Association. 2004 Apr 28;291(16):1999-2006.
Al Faraj, S et al. “Vitamin D deficiency and chronic low back pain in Saudi Arabia.” Spine. 2003 Jan 15;28(2):177-9.
McAlindon TE, et al. “Relation of dietary intake and serum levels of vitamin D to progression of osteoarthritis of the knee among participants in the Framingham Study.” Annals of Internal Medicine. 1996 Sep 1;125(5):353-9.
*The views and opinions expressed by contributors and or product reviews are their own and not
necessarily those of NatureCity. These reviews should not be taken as recommendations but rather
client opinions of the products that they have used.
TrueCirc - Advanced Artery and Circulation Support
Features AstaREAL® astaxanthin, EVNol SupraBio™ tocotrienols and MenaQ7® Vitamin K2.
shop now!$49.97 –$248.97